United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharma service co llc austria - 40g [20x2g filter tea bag] - bag - combination - gastrointestinal system-laxatives

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

elder flower, lime flower, folium plantaginis, roship shells

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

chamomile (matricaria)flowers,folium malvae,folium menthae pipettae,herba centaurti,radix calamus,fructus foeniculi

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

flos charmomillae vulgaris,folium menthae piperitae,folium menyanthis,herba teucrii,herba taraxacicum radix

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

folium malvae,folium menthae piperitae,fructus carvi,fructus foeniculi & herba centaurii

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

frangula bark,senna leaf,peppermint leaf,fennel,caraway fruit

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

orange flower,hawthorn leaf with flower,mate leaf,peppermint leaf,rosemary leaf

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

flos lipuli,flos aurantil naturalis,folium melisaae,folium menthae pipertae,radix valerianae

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

folium menthae piperitae,folium orthosiphonis,herba equiseti,herba herniarlae,radix onondis

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - rosuvastatin - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; rosuvastatin - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular even